Rena D. Callahan, MD

• Breast Cancer
• Treating side effects of cancer therapy

1. Evaluation of an NP-based model of palliative care delivery within an oncology clinic. Sarah F. DAmbruoso, Neil Wenger, Anne Coscarelli, Sara A. Hurvitz, Christopher Pietras, Meghan Nechrebecki, Jennie Kung, Rena Desai Callahan, Jonathan Wade Goldman, Parvin F. Peddi, Drakaki Alexandra, Samuel A. Skootsky, and Anne Margaret Walling Journal of Clinical Oncology20173531_suppl163-163
2. R J Hartmaier, S E Trabucco, N Priedigkeit, J H Chung, C A Parachoniak, P Vanden Borre, S Morley, M Rosenzweig, L M Gay, M E Goldberg, J Suh, S M Ali, J Ross, B Leyland-Jones, B Young, C Williams, B Park, M Tsai, B Haley, J Peguero, R D Callahan, I Sachelarie, J Cho, J M Atkinson, A Bahreini, A M Nagle, S L Puhalla, R J Watters, Z Erdogan-Yildirim, L Cao, S Oesterreich, A Mathew, P C Lucas, N E Davidson, A M Brufsky, G M Frampton, P J Stephens, J Chmielecki, A V Lee; Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer, Annals of Oncology, Volume 29, Issue 4, 1 April 2018, Pages 872–880, https://doi.org/10.1093/annonc/mdy025
3. Jennifer S. Woo, Neda A. Moatamed, Peggy S. Sullivan, David Y. Lu, Rena Callahan et al. (2015) Comparison of Phosphohistone H3 Immunohistochemical Staining, Ki-67, and H&E Mitotic Count in Invasive Breast Carcinoma. Journal Of Breast Cancer Survival - 1(1):1-11.
4. Ponec, R., Peddi, P., Callahan, R. "Parp inhibitors in Breast Cancer: Latest Evidence." Current Breast Cancer Reports. Vol 9, 2017.
5. Rena Callahan. Ado-Trastuzumab Emtansine in Metastatic HER2-Positive Breast Cancer. J Adv Pract Oncol. 2014 Mar-Apr; 5(2): 134–139.
6. Rena D. Callahan, Patricia A. Ganz. “Side Effects of Systemic Therapy: Neurocognitive, Cardiac, and Secondary Malignancies.” Diseases of the Breast, 5th edition, Ed. Jay R. Harris, MD, Marc E. Lippman, MD, Monica Morrow, MD, and C. Kent Osborne, MD. Lippincott Williams and Wilkins, May 2014, 1224. ISBN: 978-1-4511-8627-7.
7. RD Callahan, SA Hurvitz. HER2-Positive Breast Cancer: Current Management of Early, Advanced, and Recurrent Disease. Current Opinions in Obstetrics and Gynecology, 2011 Feb. 23 (1):37-43.
8. R.Callahan, R. Patel, D.Chan, M.Allison, B. Dicarlo, L. Bosserman, A. Kennedy, L.M. Zehngebot, J. Miller, A.E. Giuliano, B. Spivack, L.S. Lin, D.J. Slamon, S.A. Hurvitz. Phase II Trial of Presurgical Treatment with Trastuzumab (H) or Lapatinib (Ty) or the Combination of Trastuzumab and Lapatinib (H+Ty), Followed by Six Cycles of Docetaxel (T) and Carboplatin (C) with Trastuzumab (TCH) or Lapatinib (TCTy) or the combination of Trastuzumab and Lapatinib (TCHTy) in Patients with HER2+ Breast Cancer. 2010 San Antonio Breast Cancer Symposium, December 2010.
9. Richard P. Tonino, Pierre J. Meunier, Ronald Emkey, Jose A. Rodriguez-Portales, Charles-Joel Menkes, Richard D. Wasnich, Henry G. Bone, Arthur C. Santora, Mei Wu, Rena Desai, and Philip D. Ross. “Skeletal benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women.” J. Clin. Endocrinol. Metab. 2000. 85: 3109-3115.
10. Rena Desai Callahan, K. Rajender Reddy. “Liver Disease in Pregnancy.” The Clinician’s Guide to Liver Disease. Ed. Reddy KR and Faust T. Philadelphia: Slack, 2006: 211-230.

• Winter 2016 Ask the Expert: Neoadjuvant Therapy(Link is external) (Link opens in new window) - lbbc.org
• The science of why human breasts are so big(Link is external) (Link opens in new window) - businessinsider.com - September 9, 2014

Other Videos

• Understanding and Treating HER2+ Breast Cancer(Link is external) - YouTube

Medical Education

• Breast Cancer 2017: Not Your Mother’s Treatment Options(Link is external) (Link opens in new window) Simms/Mann – UCLA Center
• Breast Cancer Treatment: Past, Present, and Future(Link is external) (Link opens in new window) - Simms/Mann – UCLA Center Vimeo
• Patient Profile 2: How Should T-DM1 Be Sequenced in HER2+ mBC?(Link is external) (Link opens in new window) OncLive.com
• Patient Profile 3: 43-Year-Old Woman With Metastatic Breast Cancer Progressing Through Multiple Lines of Therapy(Link is external) (Link opens in new window) source: OncLive.com

Note: News links may expire without notice.

• Super Doctors® Southern California, 2021-2024
• Castle Connolly Top Doctors, 2018-2024
• Super Doctors Southern California Rising Stars, 2016-2018
• Henry Mayo Newhall Hospital Foundation, "Healthcare Hero", 2015-2018
• Commendation for Excellence in Medical Student Teaching, UCLA, 2005-2007
• Russell J. Stumacher Memorial Award, for academic and artistic excellence, University of Pennsylvania School of Medicine, 2004
• Glasgow Rubin Award, for academic excellence, University of Pennsylvania School of Medicine, 2004
• Alpha Omega Alpha medical honor society, inducted 2003
• Yale Class of 1956, Summer Fellowship for Study Abroad, 1996

• uclahealth.org/community-cancercare
• uclahealth.org/community-cancercare/santa-clarita
• uclahealth.org/santa-clarita
• uclahealth.org/community-cancercare/santa-monica
• uclahealth.org/community-cancercare/smoncologyparkside
• uclahealth.org/breasthealth